Table 4.
Means, 95% confidence intervals, and percentages for COVID-19 symptom data among those participants who tested positive for COVID-19. Statistical tests of significance were determined using chi-square (for categorical variables) and t-tests (for continuous variables). Effect sizes (Hedge's g) were also provided for all continuous outcome variables.
| Insomnia |
No Insomnia |
p-value | g | |
|---|---|---|---|---|
| (n = 25) | (n = 124) | |||
| # participants that endorsed symptoms, n (%) | 22 (88.0) | 114 (92.0) | n.s. | – |
| Symptom count, mean (95% CI) | 7.40 (5.85–8.95) | 7.02 (6.32–7.71) | n.s. | 0.10 |
| Overall symptom severity rating, mean (95% CI) | 1.32 (0.94–1.70) | 1.02 (0.85–1.20) | n.s. | 0.31 |
| Mean symptom severity rating, mean (95% CI) | 1.86 (1.53–2.19) | 1.54 (1.40–1.69) | 0.08 | 0.39 |
| Symptom duration in days, mean (95% CI) | 24.8 (17.09–32.41) | 16.1 (12.72–19.57) | 0.04 | 0.45 |
Note: overall symptom severity ratings were based on a single-item response to “How severe were your COVID-19 symptoms?“, whereas mean symptom severity was computed based on the average severity rating of the symptoms endorsed by each participant.